This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Willimsky, G. Articles by Blankenstein, T. Search for Related Content PubMed PubMed Citation Articles by Willimsky, G. Articles by Blankenstein, T.

Interleukin-7/B7.1-encoding Adenoviruses Induce Rejection of Transplanted but not Nontransplanted Tumors¹

Max-Delbrück-Center for Molecular Medicine, 13092 Berlin, Germany

Most cancer vaccine trials are based on efficacy studies against transplanted mouse tumors that poorly reflect the clinical situation. We constructed adenoviruses expressing interleukin-7 and B7.1 and tested their therapeutic efficacy after transfer into established transplanted and nontransplanted 3-methylcholanthrene-induced tumors. The adenoviruses efficiently induced rejection of transplanted tumors, leaving behind systemic immunity. Against nontransplanted tumors of similar size, there were almost no therapeutic effects. This result was not due to the site of tumor development, tumor type, general immune suppression, or differences in transduction efficacy. Adenoviral expression of ß-galactosidase as a surrogate antigen in nontransplanted tumors induced cytotoxic T cells that were unable to quantitatively reach the tumor site. Based on rigorous mouse models and an effective in situ immunization procedure, it is suggested that cancer vaccines can be effective, if at all, against "minimal residual disease"; additional experimental procedures must be found against established nontransplanted tumors.

This article has been cited by other articles:

				P. J. Staton, A. B. Carpenter, and S. H. Jackman IL-7 Is a Critical Factor in Modulating Lesion Development in Skn-Directed Autoimmunity J. Immunol., April 1, 2006; 176(7): 3978 - 3986. [Abstract] [Full Text] [PDF]

				N. Garbi, B. Arnold, S. Gordon, G. J. Hammerling, and R. Ganss CpG Motifs as Proinflammatory Factors Render Autochthonous Tumors Permissive for Infiltration and Destruction J. Immunol., May 15, 2004; 172(10): 5861 - 5869. [Abstract] [Full Text] [PDF]

				S. Ibe, Z. Qin, T. Schuler, S. Preiss, and T. Blankenstein Tumor Rejection by Disturbing Tumor Stroma Cell Interactions J. Exp. Med., November 26, 2001; 194(11): 1549 - 1560. [Abstract] [Full Text] [PDF]

				K. Schumacher, W. Haensch, C. Röefzaad, and P. M. Schlag Prognostic Significance of Activated CD8+ T Cell Infiltrations within Esophageal Carcinomas Cancer Res., May 1, 2001; 61(10): 3932 - 3936. [Abstract] [Full Text]

				B. M. Putzer, T. Stiewe, F. Rodicker, O. Schildgen, S. Ruhm, O. Dirsch, M. Fiedler, U. Damen, B. Tennant, C. Scherer, et al. Large Nontransplanted Hepatocellular Carcinoma in Woodchucks: Treatment With Adenovirus-Mediated Delivery of Interleukin 12/B7.1 Genes J Natl Cancer Inst, March 21, 2001; 93(6): 472 - 479. [Abstract] [Full Text] [PDF]

				T. S. Griffith, R. D. Anderson, B. L. Davidson, R. D. Williams, and T. L. Ratliff Adenoviral-Mediated Transfer of the TNF-Related Apoptosis-Inducing Ligand/Apo-2 Ligand Gene Induces Tumor Cell Apoptosis J. Immunol., September 1, 2000; 165(5): 2886 - 2894. [Abstract] [Full Text] [PDF]